InterMune (NASDAQ:ITMN) more than doubled Tuesday to its highest value since May 2011 after saying data from a phase 3 trial showed its Pirfenidone drug significantly reduced the progression of idiopathic pulmonary fibrosis. Near midday, ITMN had jumped 126.6% at $31.63 per share in recent trading. Earlier it hit $37.22. Also, significant treatment effects were…
Home Depot (NYSE:HD) reported Q4 sales shy of expectations Tuesday morning while also beating on EPS and hiking its dividend. Home Depot has just favored a long-term reversal pattern between the sessions, cutting back or reversing course in the following regular sessions after 20 of the last 36 pre-market earnings events we’ve tracked. Looking deeper…
On Jan 15, Williams Companies, Inc. (NYSE:WMB) announced that it delivered a record amount of natural gas on its Transco interstate gas pipeline to meet demand driven by recent cold weather in markets on the U.S. Eastern Seaboard. Two recently completed expansions of Transco, totaling 315,000 dekatherms per day (dth/d) of natural gas transportation capacity,…
Shares of Ambev SA (NASDAQ:ABEV) have received an average rating of “Buy” from the six ratings firms that are covering the company, Stock Ratings Network reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. Ambev S.A. (NYSE:ABEV) belongs to Consumer Goods sector….
Collectors Universe, Inc. (NASDAQ:CLCT), announced that its Board of Directors has approved an increase in its quarterly cash dividend to $0.35 per share per quarter, for an expected total annual cash dividend of $1.40 per common share. Collectors Universe Inc. (NASDAQ:CLCT) belongs to Services sector. Its net profit margin is 14.70% and weekly performance is…
Strides Arcolab, announced that it has entered into a licensing agreement with Gilead Sciences Inc. (NASDAQ:GILD)under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), both as a single agent product and in combination with other drugs. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin…
